Skip to search formSkip to main contentSkip to account menu

IPD 1151T

Known as: IPD-1151T 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

suplatast tosilate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Beneficial effects of suplatast tosilate (IPD‐1151T) in a rat cystitis model induced by intravesical hydrochloric acid
To examine the effects of suplatast tosilate (IPD‐1151T), a Th2 cytokine inhibitor recently recognized to improve the symptoms in… 
1998
1998
Prophylactic Efficacy of IPD【○!R】(Suplatast Tosilate) for Japanese Cedar Pollinosis
Suplatast tosilate is a novel drug which specifically suppresses the production of IgE antibodies. We evaluated the efficacy of… 
1995
1995
Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
We investigated the effect of IPD-1151T (Suplatast Tosilate, (+/-)-[2-[4-(3-ethoxy-2-hydroxypropoxy) phenyl-carbamoyl]-ethyl… 
Highly Cited
1994
Highly Cited
1994
Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response.
The ability of IPD-1151T to suppress the induction of human IgE synthesis was investigated with an in vitro model of IgE… 
Highly Cited
1993
Highly Cited
1993
Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1). Regulation of murine IgE response.
The effect of IPD-1151T, a new dimethylsulfonium compound, on the IgE response was investigated in the mouse system. The oral… 
1993
1993
[Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice].
We examined the effects of suplatast tosilate (IPD-1151T) on antibody formation in mice, and the following results were obtained… 
1992
1992
[Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].
We examined the effect of suplatast tosilate (IPD-1151T), which exhibits a class-specific suppression of IgE antibody production… 
1992
1992
Pharmacokinetic Studies of Suplatast tosilate (IPD-1151T) (IV) : Dose dependency and sex difference of Suplatast tosilate (IPD-1151T) in Rats
The dose-dependent pharmacokinetics of suplatast tosilate, (±)-[2-[4-(3-ethoxy-2-hydroxypropoxy) phenylcarbamoyl]ethyl… 
1992
1992
Antiallergic agents for atopic dermatitis.Clinical evaluation of IPD-1151T.
アトピー性皮膚炎患者40例に抗アレルギー剤であるIPD-1151 T(トシル酸スプラタスト)を8週間投与し, その臨床効果を検討した。その結果, 皮膚症状は, そう痒, 皮疹とも明らかな改善を示し, 最終全般改善度において中等度改善以上の改善率で79.4… 
1992
1992
IPD-1151T: a prototype drug for IgE antibody synthesis modulation.
IPD-1151T [(+/-)-[2-[4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate] inhibits not only… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)